The International Network on Health and Hepatitis in Substance Users (INHSU), in collaboration with the Coalition for Global Hepatitis Elimination (CGHE), FIND, The Kirby Institute, UNSW, and Clinton Health Access Initiative (CHAI), announced the release of a comprehensive report stemming from the INHSU Hepatitis C Point-of-Care Testing Forum, held during the Global Hepatitis Summit in Paris in April 2023.
Despite advances in treatment, an estimated 57 million people are living with chronic hepatitis C infection globally, with 290,000 people dying from HCV-related cirrhosis and liver cancer each year. Scaling up testing and utilising innovative testing methods are integral if the World Health Organization’s (WHO) 2030 elimination targets are to be met.
The Barriers and solutions to increasing access to point-of-care HCV testing report, developed in response to the urgent need for effective strategies to combat the global burden of HCV, explores the underutilised promise of point-of-care testing in simplifying diagnosis, improving access to treatment, and ultimately reducing the prevalence of HCV.
The report underscores the urgent need for action to address challenges in these five key areas and provides practical solutions for implementation alongside real-world examples of successful Point-of-Care programs from Catalonia, Iran, Denmark and more. It is a valuable resource for policymakers, healthcare professionals, and organisations committed to advancing global HCV elimination goals.
The International Network on Hepatitis in Substance Users (INHSU) is an international, not-for-profit, member-based organization dedicated to scientific knowledge exchange, education, and advocacy focused on improving health for people who use drugs, including focusing on hepatitis C prevention and care for people who use drugs.
INHSU annual conferences are a unique opportunity to connect with the global community working to improve health outcomes for people who use drugs including the prevention, treatment and care of hepatitis C. Their 9th International Conference on Hepatitis Care in Substance Users will be held 8 – 10 October 2020 in Glasgow, Scotland, UK.
Focused on supporting scientific exchange and knowledge dissemination, the conference provides delegates with access to the latest research and evidence regarding effective treatment and care to improve health outcomes for people who use drugs, with a specific focus on hepatitis C prevention, treatment and care. It provides an opportunity for those working in this area to share their research and professional expertise with leaders working in this field. It profiles cutting edge practice that links people who use drugs to prevention, treatment and care in a range of clinical, custodial and community settings.
This conference also brings together leaders engaged in the global effort to eliminate viral hepatitis by 2030.
Have a look at the conference promotional video
A number of scholarship opportunities are available for the full or partial scholarships for the Conference.
A full scholarship will include: conference registration, return economy class flights and accommodation. A partial scholarship will include conference registration.
To apply you must be currently enrolled in a BSc, PhD or Masters Degree and submit an abstract before the deadline: Sunday 15 March 2019.
For more information and to apply, follow this link>>>